SEMA3A and hepatocellular carcinoma: When we combined the Sema3A expression and TAM presence to evaluate the effect on HCC prognosis, we found that the OS rates of the Sema3Ahigh/intratumoral macrophageshigh patients at 1, 3, and 5 years were 84.6%, 57.3%, and 43.1%, respectively.